See Table 8.16 for comparison between treatments identified in Chapter 6 and new treatments identified from the interview process for exposure to new risks.
Table 8.16 Treatments for Change of Consortium Members / Change to Public Partner's Agency Authority.
| Treatments Identified in Previous | New Treatments Identified From |
| Exposure to new risks | |
| - Update / report on risk registers, business continuity plans, issue logs etc (Chapter 4 - 4.2, 4.3, Chapter 5 - 5.2, Chapter 6 - 6.4) | - Distillation and documentation of key commercial and project learning (PT03, RK05, RK06) - Probity checks (PT11, PT14) - Succession planning (RK05) - Stakeholder management planning (RK07) - Communication planning (RK07) - Issues management planning (RK07) |